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Streptococcus pneumoniae (the pneumococcus) remains a major cause of morbidity 
and mortality worldwide, particularly in young children and the elderly. It is responsible for a 
spectrum of diseases ranging from otitis media, to potentially fatal conditions such as 
pneumonia and meningitis, and is estimated to cost health services billions of dollars each 
year. The interaction of S. pneumoniae with the host generally begins in the nasopharynx, 
and invasive disease is almost invariably preceded by nasopharyngeal colonisation. In some 
circumstances, S. pneumoniae may translocate from the nasopharynx to the lungs where 
pneumonia can develop, and inflammation is believed to play a role in this process. The 
presence of pneumococci in the lungs also triggers an inflammatory response, which is 
important for clearance of the bacteria. However, a prolonged inflammatory response leads to 
tissue damage, and is linked with a poor prognosis of disease. It has been shown that 
respiratory epithelial cells are able to play an active part in the response to respiratory 
pathogens by releasing chemokines that are responsible for neutrophil recruitment, and it has 
recently been shown that infection of type II pneumocytes with S. pneumoniae leads to the 
release of interleukin (IL)-8. In order to determine the role of specific pneumococcal factors 
in eliciting a CXC chemokine response from type II pneumocytes (A549) and nasopharyngeal 
cells (Oetroit-562), monolayers of these cells were infected with wild type (WT) S. 
pneumoniae 039, or mutants deficient in choline binding protein A (CbpA), pneumococcal 
surface protein A (PspA), or pneumolysin (Ply), and the CXC chemokine mRNA response 
was measured by real-time RT-PCR. Release of IL-8 was also measured by ELISA. :" 
response to WT 039, both A549 and Oetroit-562 cells showed a significant increase in CXC 
chemoki¸le mRNA, and IL-8 protein. This response was increased 2-fold when a CbpA­
negative (i1CbpA) mutant was used to infect cells, suggesting that CbpA may have an 
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inhibitory effect on the CXC chemokine response of these cells. Further investigatiDn 
demonstrated that this activity is dependent on the N-terminal region of CbpA and that all 
three N-terminal domains are required for this effect, as deletion of any one of these domains 
had the same effect on the CXC chemDkine response as removing CbpA altogether. 
Infection with a PspA-negative mutant (L\PspA) led to a 2-fold decrease in the CXC 
chemokine response of A549 cells, compared to infection with WT 039 at 2 h, but no 
difference was seen in the response of Oetroit-562 cells to this mutant compared to WT 039. 
Thus, PspA appears to have the ability to stimulate an early CXC chemokine release from 
A549 cells. Deletion of the first of 2 regions of the N-terminal a-helical domain of PspA 
reduced the ability of S pneumoniae to elicit a chemokine response to the same degree as 
removing PspA altogether, indicating that it is this region that is responsible for the 
chemokine inducing ability of PspA. 
Ply appeared to have no effect on the CXC chemokine response of A549 cells with no 
obvious difference seen in the response of these cells to L\Ply compared to WT D39. 
However, infection of Detroit-562 cells with Mly led to a 2-fold decrease in IL-8 mRNA and 
protein release compared to WT D39. Using D39 strains producing mutant forms of Ply with 
reduced cytotoxicity and/or complement activating abilities, the role of the cytotoxic activity 
of Ply was demonstrated to be important in generation of a chemokine response from both 
cell lines. Infection of A549 or Oetroit-562 cells with mutants producing Ply with only 
0.02% or 0.1 % haemolytic activity led to a 2-fold decrease in IL-8 release compared to that 
elicited by WT 039. The complement activating ability of Ply also appeared to be important 
in the generation of a CXC chemokine response from A549 cells. Cells infected with a 
mutant that produced Ply with no complement activating ability released significantly less IL-
8 than cells infected with WT 039. This activity of Ply did not appear to have an effect on 
the CXC chemokine release of Detroit-562 cells. Thus all three virulence factors investigated 
had some role in the ability of S. pneumoniae to generate a CXC chemokine response from 
respiratory epithehal cells, although roles and cell were affected differed. 
